Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H9NO2 |
| Molecular Weight | 103.1198 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(N)C(O)=O
InChI
InChIKey=FUOOLUPWFVMBKG-UHFFFAOYSA-N
InChI=1S/C4H9NO2/c1-4(2,5)3(6)7/h5H2,1-2H3,(H,6,7)
| Molecular Formula | C4H9NO2 |
| Molecular Weight | 103.1198 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of acute hyperosmolality on blood-brain barrier function in ovine fetuses and lambs. | 2006-10 |
|
| Effects of multiple courses of antenatal corticosteroids on blood-brain barrier permeability in the ovine fetus. | 2006-05 |
|
| In vitro and in vivo effect of parathyroid hormone analogue (1-14) containing -amino-iso-butyric acid residue (Aib)1,3. | 2006-04-30 |
|
| [Synergistic effects of biotic and abiotic elicitors on the production of tanshinones in Salvia miltiorrhiza hairy root culture]. | 2006-02 |
|
| Gold nanoclusters protected by conformationally constrained peptides. | 2006-01-11 |
|
| Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex. | 2005-12 |
|
| Pharmacological actions of Cordyceps, a prized folk medicine. | 2005-12 |
|
| Improved solid-phase synthesis of alpha,alpha-dialkylated amino acid-rich peptides with antimicrobial activity. | 2005-12 |
|
| Analysis of the lipophilic peptaibol alamethicin by nonaqueous capillary electrophoresis-electrospray ionization-mass spectrometry. | 2005-11 |
|
| Theoretical prediction of gas-phase infrared spectra of imidazo[1,2-a]pyrazinediones and imidazo[1,2-a]imidazo[1,2-d]pyrazinediones derived from glycine. | 2005-09 |
|
| Acceleration of short helical peptide conformational dynamics by trifluoroethanol in an organic solvent. | 2005-07 |
|
| Helix-helix interconversion rates of short 13C-labeled helical peptides as measured by dynamic NMR spectroscopy. | 2005-06-05 |
|
| Effects of tumor necrosis factor-alpha on insulin stimulated amino acid transport in cultured rat hepatocytes. | 2005-06 |
|
| Fungal biosynthesis of non-ribosomal peptide antibiotics and alpha, alpha-dialkylated amino acid constituents. | 2005-06 |
|
| Preferred conformations of peptides containing tert-leucine, a sterically demanding, lipophilic alpha-amino acid with a quaternary side-chain Cbeta atom. | 2005-04-08 |
|
| Effects of 17beta-estradiol on blood-brain barrier disruption in focal ischemia during GABA(A) receptor inhibition. | 2005-04 |
|
| Chromium(V) peptide complexes: synthesis and spectroscopic characterization. | 2005-02-21 |
|
| Beta-turn mimic in tripeptide with Phe(1)-Aib(2) as corner residues and beta-strand structure in an isomeric tripeptide: an X-ray diffraction study. | 2005-02-21 |
|
| A new 2 methylalanine-PVC ESR dosimeter. | 2005-02 |
|
| Evidence against the hopping mechanism as an important electron transfer pathway for conformationally constrained oligopeptides. | 2005-01-19 |
|
| Bioactive N-terminal undecapeptides derived from parathyroid hormone: the role of alpha-helicity. | 2005-01 |
|
| Cicadapeptins I and II: new Aib-containing peptides from the entomopathogenic fungus Cordyceps heteropoda. | 2005-01 |
|
| Amino-terminal parathyroid hormone fragment analogs containing alpha,alpha-di-alkyl amino acids at positions 1 and 3. | 2004-12 |
|
| Ethylene synthesis and auxin augmentation in pistil tissues are important for egg cell differentiation after pollination in maize. | 2004-10 |
|
| Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid. | 2004-08-06 |
|
| Synthesis and characterization of a series of homooligopeptide peroxyesters. | 2004-08-05 |
|
| Conformational switching caused by biphenyl substitution at the Calpha position: ethyl 2-benzyl-2-(formylamino)-3-phenylpropionate and ethyl 3-(1,1'-biphenyl-4-yl)-2-(formylamino)-2-(4-phenylbenzyl)propionate. | 2004-07 |
|
| Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue. | 2004-05-28 |
|
| A novel 11-residual peptaibol-derived carrier peptide for in vitro oligodeoxynucleotide delivery into cell. | 2004-05-17 |
|
| Linkage of interactions in sickle hemoglobin fiber assembly: inhibitory effect emanating from mutations in the AB region of the alpha-chain is annulled by a mutation at its EF corner. | 2004-05-07 |
|
| Transcellular transport of radioiodinated 3-iodo-alpha-methyl-L-tyrosine across monolayers of kidney epithelial cell line LLC-PK1. | 2004-05 |
|
| Analysis of peptaibol sequence composition: implications for in vivo synthesis and channel formation. | 2004-05 |
|
| Metal ion-binding ability of tetrapeptides containing alpha-aminoisobutyric acid. | 2004-03 |
|
| New tools for the control of peptide conformation: the helicogenic Calpha-methyl, Calpha-cyclohexylglycine. | 2004-02 |
|
| Conformational changes in alamethicin associated with substitution of its alpha-methylalanines with leucines: a FTIR spectroscopic analysis and correlation with channel kinetics. | 2004-01 |
|
| Biosynthetic uniform 13C,15N-labelling of zervamicin IIB. Complete 13C and 15N NMR assignment. | 2003-12-09 |
|
| Trichogin: a paradigm for lipopeptaibols. | 2003-12-09 |
|
| Designed helical peptides inhibit an intramembrane protease. | 2003-10-01 |
|
| Effect of alpha,alpha-dialkyl amino acids on the protease resistance of peptides. | 2003-10 |
|
| Crystal structure of achiral nonapeptide Boc-(Aib-DeltaZPhe)4-Aib-OMe at atomic resolution: evidence for a 3(10)-helix. | 2003-10 |
|
| Sequence analysis and functional characterization of the dialkylglycine decarboxylase gene DGD1 from Mycosphaerella graminicola. | 2003-08 |
|
| Disruption of the beta-sheet structure of a protected pentapeptide, related to the beta-amyloid sequence 17-21, induced by a single, helicogenic C(alpha)-tetrasubstituted alpha-amino acid. | 2003-07 |
|
| Unique antitumour effects of L-2,4 diaminobutyric acid on cultured hepatoma cells. | 2003-06-25 |
|
| First crystallographic signature of an acyclic peptide nanorod: molecular mechanism of nanorod formation by a self-assembled tetrapeptide. | 2003-06-21 |
|
| Prevention of peptide fibril formation in an aqueous environment by mutation of a single residue to Aib. | 2003-04-22 |
|
| Functional and molecular characteristics of system L in human breast cancer cells. | 2003-04-01 |
|
| The effect of the cyclopropyl group on the conformation of chemotactic formyl tripeptides. | 2003-04 |
|
| Solution phase synthesis of the 14-residue peptaibol antibiotic trichovirin I. | 2003-04 |
|
| Ethyl 2-formamido-2-(4-iodobenzyl)-3-(4-iodophenyl)propionate and ethyl 2-(3-bromobenzyl)-3-(3-bromophenyl)-2-formamidopropionate. | 2003-04 |
|
| A MAPK pathway mediates ethylene signaling in plants. | 2003-03-17 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:35:44 GMT 2025
by
admin
on
Mon Mar 31 17:35:44 GMT 2025
|
| Record UNII |
1E7ZW41IQU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
40599
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | |||
|
6119
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | |||
|
DB02952
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | |||
|
27971
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | |||
|
200-544-0
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | |||
|
62-57-7
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | |||
|
C100049
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | |||
|
DTXSID0058772
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | |||
|
2-AMINOISOBUTYRIC ACID
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | |||
|
m1712
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | Merck Index | ||
|
1E7ZW41IQU
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY | |||
|
16590
Created by
admin on Mon Mar 31 17:35:44 GMT 2025 , Edited by admin on Mon Mar 31 17:35:44 GMT 2025
|
PRIMARY |